Rathmell: We must support our junior colleagues “Empathy and listening is a key place to start”

America needs a new blueprint for the National Cancer Program
First step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

Recently, a friend lent me a copy of a decades-old report, and by old, I mean a classic.

April 10, 2026

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.

Cancer AI Alliance announces first wave of pilot projects

Cancer AI Alliance announced its first wave of eight pilot projects across a federated learning platform. These projects represent the first wave of the organization’s efforts and aim to demonstrate that it is possible to analyze vast amounts of data while keeping patient privacy secure at the local level.

April 10, 2026

Vol.52 No.14

Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.

March 27, 2026

Vol.52 No.12

By Richard M. Goldberg

Beyond the lab: Engineering collaboration in modern cancer research

Cancer research increasingly demands environments that mirror the biology it seeks to understand: Complex, adaptive and deeply interconnected. At Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, collaboration is not treated as an optional cultural trait but as a structural requirement.

March 27, 2026

Vol.52 No.12

Clinical Roundup

Computational model measures key aging metric from routine biopsies, Sanford Burnham study finds

A computational tool infers changes occurring at the ends of the chromosomes housing our DNA, which it does so by detecting structural alterations in cells and tissues captured in images taken of routine medical biopsies, according to a study by scientists at Sanford Burnham Prebys Medical Discovery Institute.

March 20, 2026

Vol.52 No.11

Rathmell: We must support our junior colleagues

“Empathy and listening is a key place to start”

YOU MAY BE INTERESTED IN

America needs a new blueprint for the National Cancer Program
First step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

Cancer AI Alliance announces first wave of pilot projects

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

Beyond the lab: Engineering collaboration in modern cancer research

Computational model measures key aging metric from routine biopsies, Sanford Burnham study finds

Renew today!

Subscriber content

Never miss an issue!

Login

Rathmell: We must support our junior colleagues

“Empathy and listening is a key place to start”

YOU MAY BE INTERESTED IN

America needs a new blueprint for the National Cancer ProgramFirst step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

California state-funded institute scraps selection process that put cancer projects at a disadvantageCancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

Cancer AI Alliance announces first wave of pilot projects

In the era of immunotherapy, response rate alone fails to predict true patient benefitRegulators must adapt

Beyond the lab: Engineering collaboration in modern cancer research

Computational model measures key aging metric from routine biopsies, Sanford Burnham study finds

Never miss an issue!

Login

America needs a new blueprint for the National Cancer Program
First step: Develop Version 2.0 of Paul Calabresi’s “Cancer at a Crossroads”

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt